RNA Analysis/Transcriptomics Market Report: Trends, Forecast and Competitive Analysis to 2030

RNA Analysis/Transcriptomics Trends and Forecast

The future of the global RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets. The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

A more than 150-page report is developed to help in your business decisions.

RNA Analysis/Transcriptomics by Segment

The study includes a forecast for the global RNA analysis/transcriptomics by product type, technology, application, end use, and region.

RNA Analysis/Transcriptomics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Consumables
• Instruments
• Software
• Services

RNA Analysis/Transcriptomics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Real Time-PCR (qPCR)
• Microarray
• Sequencing
• Others

RNA Analysis/Transcriptomics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Drug Discovery
• Diagnostics & Disease Profiling
• Others

RNA Analysis/Transcriptomics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Government Institutes & Academic Centers
• Pharmaceutical & Biotechnology
• Hospitals & Clinics
• Contract Research Organizations (CROs)
• Others

RNA Analysis/Transcriptomics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of RNA Analysis/Transcriptomics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA analysis/transcriptomics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA analysis/transcriptomics companies profiled in this report include-

• Agilent Technologies
• F. Hoffmann-La Roche
• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Eurofins Scientific
• Merck KGaA
• Bio-Rad Laboratories
• Pacific Bioscience of California
• Affymetrix

RNA Analysis/Transcriptomics Market Insights

Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Features of the Global RNA Analysis/Transcriptomics Market

Market Size Estimates: RNA analysis/transcriptomics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: RNA analysis/transcriptomics market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: RNA analysis/transcriptomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the RNA analysis/transcriptomics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA analysis/transcriptomics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the RNA analysis/transcriptomics market size?

Answer: The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030.

Q2. What is the growth forecast for RNA analysis/transcriptomics market?

Answer: The global RNA analysis/transcriptomics market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the RNA analysis/transcriptomics market?

Answer: The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

Q4. What are the major segments for RNA analysis/transcriptomics market?

Answer: The future of the RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets.

Q5. Who are the key RNA analysis/transcriptomics market companies?

Answer: Some of the key RNA analysis/transcriptomics companies are as follows:

• Agilent Technologies
• F. Hoffmann-La Roche
• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Eurofins Scientific
• Merck KGaA
• Bio-Rad Laboratories
• Pacific Bioscience of California
• Affymetrix

Q6. Which RNA analysis/transcriptomics market segment will be the largest in future?

Answer: Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

Q7. In RNA analysis/transcriptomics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the RNA analysis/transcriptomics market by product type (consumables, instruments, software, and services), technology (real time-pcr (qPCR), microarray, sequencing, and others), application (drug discovery, diagnostics & disease profiling, and others), end use (government institutes & academic centers, pharmaceutical & biotechnology, hospitals & clinics, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?